Technical Analysis for AVRO - AVROBIO, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.37 | 6.20% | 0.08 |
AVRO closed up 6.2 percent on Wednesday, May 15, 2024, on 2.75 times normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
Stochastic Reached Overbought | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% |
Alert | Time |
---|---|
10 DMA Support | about 22 hours ago |
50 DMA Support | about 22 hours ago |
Jack-in-the-Box Bullish Entry | about 22 hours ago |
Rose Above Previous Day's High | about 22 hours ago |
Rose Above Upper Bollinger Band | about 22 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Virotherapy Gene Therapy Medical Genetics Genetic Engineering Gene Delivery
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Virotherapy Gene Therapy Medical Genetics Genetic Engineering Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.7 |
52 Week Low | 0.6255 |
Average Volume | 212,639 |
200-Day Moving Average | 1.39 |
50-Day Moving Average | 1.26 |
20-Day Moving Average | 1.24 |
10-Day Moving Average | 1.27 |
Average True Range | 0.06 |
RSI (14) | 64.66 |
ADX | 29.67 |
+DI | 24.18 |
-DI | 12.00 |
Chandelier Exit (Long, 3 ATRs) | 1.20 |
Chandelier Exit (Short, 3 ATRs) | 1.35 |
Upper Bollinger Bands | 1.33 |
Lower Bollinger Band | 1.14 |
Percent B (%b) | 1.18 |
BandWidth | 15.90 |
MACD Line | 0.02 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0168 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.57 | ||||
Resistance 3 (R3) | 1.55 | 1.46 | 1.54 | ||
Resistance 2 (R2) | 1.46 | 1.41 | 1.47 | 1.53 | |
Resistance 1 (R1) | 1.42 | 1.38 | 1.44 | 1.44 | 1.52 |
Pivot Point | 1.33 | 1.33 | 1.34 | 1.34 | 1.33 |
Support 1 (S1) | 1.28 | 1.28 | 1.31 | 1.30 | 1.22 |
Support 2 (S2) | 1.19 | 1.24 | 1.20 | 1.21 | |
Support 3 (S3) | 1.15 | 1.19 | 1.20 | ||
Support 4 (S4) | 1.17 |